Daren Graham – GeneTether, Inc.

by Daren Graham

December 6, 2024

MANAGEMENT INFORMATION CIRCULAR AND PROXY – ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF GENETETHER THERAPEUTICS INC. TO BE HELD ON DECEMBER 12, 2024

0

by Daren Graham

December 3, 2024

GeneTether Therapeutics Inc. Announces Arrangements to Address Mailing Delays from Canada Post Strike

Vancouver, British Columbia – December 2, 2024 – GeneTether Therapeutics Inc. (together with its whollyowned subsidiary […]

0

by Daren Graham

December 3, 2024

GeneTether Therapeutics Inc. Announces Third Quarter 2024 Financial Results

NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED […]

0

by Daren Graham

October 17, 2024

GeneTether Therapeutics Announces Binding Term Sheet for Private Placement of Units and Exclusive License Agreement of Soft Tissue Sarcoma Drug Candidate

KELOWNA, BC & SAN JUAN, PR – October 11, 2024 – TheNewswire – GeneTether Therapeutics Inc. (CSE: GTTX) […]

0

by Daren Graham

September 23, 2024

GeneTether Therapeutics Inc. Announces Second Quarter 2024 Financial Results

NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED […]

0

by Daren Graham

GeneTether Therapeutics Inc. Announces Fiscal Year 2023 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – March 28, 2024

0